Avis Budget Group trades at $75.35 per share and has stayed right on track with the overall market, losing 6.1% over the last six months while the S&P 500 is down 9%. This was partly due to its softer quarterly results and might have investors contemplating their next move.
3 Reasons ATRO is Risky and 1 Stock to Buy Instead
Since April 2020, the S&P 500 has delivered a total return of 85%. But one standout stock has more than doubled the market - over the past five years, Astronics has surged 197% to $24 per share. Its momentum hasn’t stopped as it’s also gained 14.1% in the last six months thanks to its solid quarterly results, beating the S&P by 23%.
3 Reasons to Avoid BWXT and 1 Stock to Buy Instead
Over the past six months, BWX’s shares (currently trading at $104.17) have posted a disappointing 16.7% loss while the S&P 500 was down 8.9%. This might have investors contemplating their next move.
Spotting Winners: Papa John's (NASDAQ:PZZA) And Traditional Fast Food Stocks In Q4
Let’s dig into the relative performance of Papa John's (NASDAQ:PZZA) and its peers as we unravel the now-completed Q4 traditional fast food earnings season.
3 Reasons to Sell BTSG and 1 Stock to Buy Instead
Even during a down period for the markets, BrightSpring Health Services has gone against the grain, climbing to $17.29. Its shares have yielded a 8.7% return over the last six months, beating the S&P 500 by 17.6%. This run-up might have investors contemplating their next move.
3 Reasons to Sell RCL and 1 Stock to Buy Instead
Since October 2024, Royal Caribbean has been in a holding pattern, posting a small loss of 4.1% while floating around $193.01.
Texas Roadhouse (TXRH): 3 Reasons We Love This Stock
Texas Roadhouse has followed the market’s trajectory closely. The stock is down 10.6% to $162.91 per share over the past six months while the S&P 500 has lost 8.9%. This might have investors contemplating their next move.
Aerospace Stocks Q4 Highlights: Rocket Lab (NASDAQ:RKLB)
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how aerospace stocks fared in Q4, starting with Rocket Lab (NASDAQ:RKLB).
3 Reasons to Avoid OLPX and 1 Stock to Buy Instead
Olaplex has gotten torched over the last six months - since October 2024, its stock price has dropped 45.5% to $1.14 per share. This may have investors wondering how to approach the situation.
Pharmaceuticals Stocks Q4 In Review: Jazz Pharmaceuticals (NASDAQ:JAZZ) Vs Peers
Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at Jazz Pharmaceuticals (NASDAQ:JAZZ) and its peers.